In a world of shifting priorities, one constant remains in long-term care: money talks.
Fast times at NIC
By
John O'Connor
Sep 05, 2024
The National Investment Center for Seniors Housing & Care Fall Conference will start soon, and the excitement already is building.
Need something else to worry about?
By
John O'Connor
Apr 30, 2020
I’m no expert on monetary policy and have never played one on TV. But even I am beginning to wonder if these actions might create another problem for senior living operators.
Why high inflation may give senior living an unexpected benefit
By
John O'Connor
Apr 21, 2022
The mix of available jobs and rising inflation is luring many recent retirees back to the workplace, which could be good for senior living.
OIG: Medicaid could save $1.4 billion by requiring rebates from generic drug makers
By
John O'Connor
Dec 21, 2015
Requiring generic drug makers to pay rebates when they raised prices faster than inflation would have trimmed $1.4 billion from Medicaid outlays over the past decade, notes a report from the Office of...
Senior living’s latest challenge carries a hefty price tag
By
John O'Connor
Feb 24, 2022
Rates charged by senior living operators rose by a robust 4.65% in 2021. In normal times, that would have been pretty wonderful news, at least from an operator’s standpoint.
Stretchable skin could give caregiving robots a more human touch
By
John O'Connor
May 06, 2024
Newly developed stretchable electronic skin might soon give robots and other devices the same softness and touch sensitivity as human skin.
Is senior living’s recession-resistant reputation in for another test?
By
John O'Connor
Jun 02, 2022
A recession this year would not be a death blow, but it may be the final straw for some operators who were struggling when the pandemic began.
Senate drug pricing bill lowers costs for seniors
By
John O'Connor
Dec 10, 2019
A new version of a Senate drug-pricing bill would trim the amount seniors would pay for medications, advocates are claiming.
Rising drug costs get a gut check
By
John O'Connor
Jun 23, 2016
One of the biggest drivers of drug costs may be something you’re not likely to see on a direct-to-consumer advertisement any time soon.